Bluechiip Receives AU$1 Million Initial Order From US Partner

Bluechiip Limited [ASX:BCT], a leader in the development of sample tracking technology for harsh environments, today announced that a licensed Original Equipment Manufacturer (OEM) partner in the United States has placed orders for Bluechiip chips, readers, software and services valued at over A$1 million.

This licensed OEM partner will use Bluechiipenabled consumables to address a variety of markets in Life Sciences including cryogenics, drug screening, cell therapy as well as forensics.

Bluechiip will supply its U.S. partner with chips, readers and software, all of which are either in production or progressing to production.

The sale follows the signing in April this year of a license and supply agreement between Bluechiip and the U.S. based OEM, allowing our partner to buy, utilize, sell, market and promote Bluechiip’s intellectual property, technology and products.

Bluechiip Managing Director Andrew McLellan said, “These are our largest orders to date and we expect it will be the start of significant growth for the company. The orders are further validation of our partnering strategy, which we put in place two years ago. We are delighted our OEM partner continues to progress into multiple markets within the Life Sciences arena.”

Read the full ASX announcement >

Contact Bluechiip for more information >